Silymarin and management of liver function in non-alcoholic steatohepatitis: a case report

Ahmed Hashem

Article Type

Case Report


This case report discusses daily treatment with silymarin and highlights moderate efficacy and a good safety profile in the management of non-alcoholic steatohepatitis (NASH) and liver function with no side-effects, supporting silymarin as a promising supplemental intervention that can normalize liver activity in non-alcoholic fatty liver disease and NASH.

Read more

Register for alerts

I would like to be contacted by Drugs in Context when new articles are posted.